ATUSHI,China,Dec. 13,2024-- Recently,the Kizilsu Kirghiz Power Supply Company of the State Grid actively organized a volunteer team and went deep into Kang\'an Community to carry out heartwarming volu
The future of business is here,and it\'s powered by artificial intelligence.
BRISBANE,Australia,Dec. 14,2024-- Click Start Digital,a leader in e-commerce business solutions,has launched its new AI-Int
ARTUSH,China,Dec. 15,2024-- On December 12,the State Grid Kizilsu Kirghiz Autonomous Prefecture Electric Power Supply Company responded quickly and actively organized professionals to carry out a comp
In the news release,Max Verstappen Joins the Celebration as Heineken\'s Player 0.0 Champion is Crowned,issued 14-Dec-2024 by Heineken over PR Newswire,we are advised by the company that a factual corr
DUBAI,UAE,Dec. 15,2024-- Huawei Consumer Business Group (CBG) unveiled its first TWS earbuds under the HUAWEI SOUND brand,the HUAWEI FreeBuds Pro 4,at the HUAWEI Flagship Launch Event in Dubai on Dece
HONG KONG,Dec. 16,2024-- Biologists from Hong Kong Baptist University (HKBU) have discovered two new species of windowpane shell at Mai Po,Hong Kongand inthe South China Sea. Also known as the windowp
SK Biopharmaceuticals,ProEn Therapeutics aim to advance up to 2 preclinical radiopharmaceutical candidates by 2027,via ArtBody™,a bivalent binder platform designed to selectively target tumor cells
On the first Wednesday of every month since 2005, rain or shine, a determined circle forms outside Osaka Station. Holding portraits of silver-haired women and signs reading "Let us build a society together where peace and human rights prevail, preserving the memory of history," members of a Japanese civil group raise voices that Tokyo has long tried to silence.
On the early morning of May 12, a 5.5-magnitude earthquake struck Lhaze county, Xigaze, Southwest China's Xizang Autonomous Region. The earthquake had a focal depth of 10 kilometers and affected surrounding areas, including Saga county.
Taipei-based biotech company Jyong Biotech Ltd. has leveraged a successful IPO to accelerate the development of MCS-2, a promising treatment for benign prostatic hyperplasia (BPH).